Literature DB >> 35713875

Risk-Adjusted Performance Measures: A Comment on Elbasha.

Pedram Sendi1, Matthias Schwenkglenks2.   

Abstract

Entities:  

Year:  2022        PMID： 35713875     DOI： 10.1007/s40273-022-01153-7

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.558


× No keyword cloud information.
  2 in total

1.  Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches.

Authors:  Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2022-02-09       Impact factor: 4.558
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.